Financials
- Market Capitalization 31.8 M
- Employee 29
- Founded 2017
- CEO N/A
- Website www.bioxceltherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00K20GVD2
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.28
Rapporto prezzo/fatturato
25.81
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4462 | BCTX BriaCell Therapeutics Corp. - Common Shares | 3.70 USD | -1.33% | +5.41% | +32.62% | +356.79% | 32.19 M USD | ||
| 4464 | SER Serina Therapeutics, Inc. Common Stock | 2.14 USD | +2.39% | -3.17% | +16.30% | +28.53% | 32.09 M USD | ||
| 4473 | DARE Dare Bioscience, Inc. - Common Stock | 2.07 USD | -0.96% | +1.47% | +2.99% | +25.45% | 31.01 M USD | ||
| 4477 | SNTI Senti Biosciences, Inc. - Common Stock | 0.97 USD | +1.04% | -5.83% | +1.04% | +1.89% | 30.21 M USD |